-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions
PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions
PharmaCielo Ltd. (OTCQX:PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. has made an initial shipment of CBD full spectrum oil containing THC to Extractions Solutions SL, a Spanish natural pharmaceutical company that specializes in the post-processing and refinement of cannabis derivatives. Extractions Solutions intends to use PharmaCielo's product to develop CBD derivatives to be produced in Spain, and distributed across Europe.
Bill Petron, CEO of PharmaCielo, stated, "We are pleased to announce our entrance into a new market, with the initial shipment of PharmaCielo API to Extractions Solutions, in support of their product development efforts. This serves to further expand our distribution network throughout Europe, building on our recent announcements that we will be bringing PharmaCielo products to the German and Polish medical cannabis markets. Our sales team has already made substantial progress in the first five months of 2022, and we expect to continue this trend through the rest of the year as we drive toward increased revenues and sustained profitability."
Dirk Eduard M. de Maeyer, executive director of Extractions Solutions, said his company was pleased to expand its product portfolio. "Extractions Solutions is an innovative, rapidly growing cannabinoid post-processor, refiner and manufacturer, with an established customer base across the European market. With a commitment to providing high quality products and custom solutions, as well as seed to solution traceability, PharmaCielo was a logical choice as we continue to build-out our product portfolio. PharmaCielo has the quality, consistency, sophistication and scale that we require of our API partners, and we look forward to continuing to advance the relationship as we seek to serve our customers across the EU, and globally," stated Maeyer.
Photo: Courtesy of Richard T on Unsplash
Related News
PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings
PharmaCielo Cuts Net Loss By 39.13% To $20.9M Despite Plummeting Revenues In 2021
Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect
PharmaCielo Ltd. (OTCQX:PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. has made an initial shipment of CBD full spectrum oil containing THC to Extractions Solutions SL, a Spanish natural pharmaceutical company that specializes in the post-processing and refinement of cannabis derivatives. Extractions Solutions intends to use PharmaCielo's product to develop CBD derivatives to be produced in Spain, and distributed across Europe.
PharmaCielo有限公司。(OTCQX:PCLOF)(多伦多证券交易所股票代码:PCLO),哥伦比亚干花和药用级大麻提取物的主要种植者和生产商的加拿大母公司,PharmaCielo哥伦比亚控股公司有制造了第一批CBD全光谱油含THC 至Exttions Solutions SL,一家西班牙天然制药公司,专门从事大麻衍生品的后处理和提炼。Exctions Solutions打算使用PharmaCielo的产品开发CBD衍生品,这些衍生品将在西班牙生产,并在欧洲各地分销。
Bill Petron, CEO of PharmaCielo, stated, "We are pleased to announce our entrance into a new market, with the initial shipment of PharmaCielo API to Extractions Solutions, in support of their product development efforts. This serves to further expand our distribution network throughout Europe, building on our recent announcements that we will be bringing PharmaCielo products to the German and Polish medical cannabis markets. Our sales team has already made substantial progress in the first five months of 2022, and we expect to continue this trend through the rest of the year as we drive toward increased revenues and sustained profitability."
比尔·彼得龙PharmaCielo的首席执行官说:“我们很高兴地宣布进入一个新的市场,PharmaCielo的第一批原料药将运往提取解决方案公司,以支持他们的产品开发工作。这有助于进一步扩大我们在整个欧洲的分销网络,基于我们最近宣布我们将把PharmaCielo的产品引入德国和波兰医用大麻市场。我们的销售团队在2022年的前五个月已经取得了重大进展,我们预计在今年余下的时间里将继续这一趋势,我们将努力实现收入的增加和持续的盈利。”
Dirk Eduard M. de Maeyer, executive director of Extractions Solutions, said his company was pleased to expand its product portfolio. "Extractions Solutions is an innovative, rapidly growing cannabinoid post-processor, refiner and manufacturer, with an established customer base across the European market. With a commitment to providing high quality products and custom solutions, as well as seed to solution traceability, PharmaCielo was a logical choice as we continue to build-out our product portfolio. PharmaCielo has the quality, consistency, sophistication and scale that we require of our API partners, and we look forward to continuing to advance the relationship as we seek to serve our customers across the EU, and globally," stated Maeyer.
德克·爱德华·M·德·梅耶董事高管Exctions Solutions表示,他的公司很高兴扩大其产品组合。Maeyer说:“Exttions Solutions是一家创新的、快速发展的大麻后处理器、精炼商和制造商,在欧洲市场拥有稳固的客户基础。PharmaCielo致力于提供高质量的产品和定制解决方案,以及种子到解决方案的可追溯性,在我们继续扩大我们的产品组合时,PharmaCielo是一个合乎逻辑的选择。PharmaCielo拥有我们对原料药合作伙伴所要求的质量、一致性、成熟度和规模,我们期待着在我们寻求为整个欧盟和全球客户服务的同时,继续推进我们的关系。”
Photo: Courtesy of Richard T on Unsplash
图片:由Richard T在UnSplash上提供
Related News
相关新闻
PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings
PharmaCielo将通过与Soteria控股公司的合作进入波兰医用大麻市场
PharmaCielo Cuts Net Loss By 39.13% To $20.9M Despite Plummeting Revenues In 2021
PharmaCielo将净亏损减少39.13%,至2090万美元,尽管2021年收入暴跌
Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect
随着新规生效,哥伦比亚的Flora Growth和PharmaCielo开始出口干花
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧